Literature DB >> 33997821

Comprehensive analysis of liver macrophage composition by flow cytometry and immunofluorescence in murine NASH.

Sabine Daemen1,2, Mandy M Chan2, Joel D Schilling1,2,3.   

Abstract

Recently, it has become evident that macrophage diversity increases in the liver during the pathogenesis of non-alcoholic steatohepatitis (NASH). Here, we provide a detailed protocol for the analysis of liver macrophage subsets in mice with non-alcoholic fatty liver disease (NAFLD) and early NASH using flow cytometry and immunofluorescence (IF). These methods can be used to assess the composition and localization of macrophage subsets during NASH. For complete details on the use and execution of this protocol, please refer to Daemen et al. (2021).
© 2021 The Author(s).

Entities:  

Keywords:  Flow Cytometry/Mass Cytometry; Immunology; Metabolism; Microscopy; Model Organisms; Single Cell

Mesh:

Year:  2021        PMID: 33997821      PMCID: PMC8102804          DOI: 10.1016/j.xpro.2021.100511

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

The protocol below describes the specific steps for isolation of liver macrophages of mice with established NASH. However, we have also used this protocol for isolation and analysis of liver macrophages of healthy, standard diet-fed mice and mice from a variety of genetic backgrounds. As antibodies to CCR2 and CX3CR1 do not work well for flow cytometry following liver digestion the use of Ccr2-GFP or Cx3cr1-GFP reporter mice can be employed to identify Ccr2/Cx3cr1-high liver macrophages. Thus, we will describe here the use of this protocol for both Ccr2/Cx3cr1-GFP and wild-type mice.

Induction of diet-induced NASH

Timing: 0–16 weeks Co-house same sex mice in specific pathogen free animal facilities with regular drinking water. If comparing wild type (WT) to knockout (KO) or transgenic mice it is critical to ensure mixing of genotypes in cages. Littermate controls should also be utilized. Induce NASH in 8-week-old mice by replacing regular chow with a NASH diet, i.e., the fructose, cholesterol, palmitate (FPC) diet or a diet with similar composition (i.e., AMLN), for at least 16 weeks. Provide fresh NASH chow weekly. Although female or male mice can be used the NASH phenotypes are more severe in male mice. Duration of feeding may need to be optimized depending on the experimental question, mouse strain and specific NASH diet. Monitor body weight and record at least every 4 weeks. If needed, perform glucose and insulin tolerance tests 1–2 weeks prior to sacrifice. Sacrifice animals and harvest liver at the end of 16 weeks NASH diet.

Key resources table

Materials and equipment

Collagenase A stock

Add 13.3 mL DMEM to 1 g collagenase A powder in the supplied vial to achieve concentration of 75 mg/mL. Vortex to mix and incubate at 37°C water bath for 30–40 min to promote dissolution. Store as 1 mL aliquots for up to 12 months at −20°C and avoid repeated freeze/thaw cycles.

DNaseI stock

Add 2 mL DI water to reconstitute 100 mg DNaseI powder in the supplied vial. Transfer solution to new 50 mL conical tube. Rinse the vial with 2 mL of DI water and transfer the rinse to the same conical tube. Add 16 mL DI water to the conical tube to achieve 5 mg/mL stock concentration. Vortex to mix and store as 1 mL aliquots for up to 12 months at −20°C. Avoid repeated freeze/thaw cycles as this will reduce enzyme activity.

Zombie Aqua stock

Prepare according to manufacturer’s instruction. Briefly, reconstitute 1 vial of lyophilized reagent with 100 μL DMSO (included in the kit). Vortex to mix. Store as 10 μL aliquots up to 6 months at −20°C and protect from light.

30% Sucrose solution

Dissolve 150 g of sucrose in 200 mL of autoclaved PBS with a magnetic stir bar. Once dissolved, add more PBS until it reaches the 500 mL line. Aliquot into 50 mL conical tubes for working solutions. Store at 20°C–24°C for up to 6 months. Complete DMEM Prepare in a sterile environment and filter through 0.22 μm PES membrane. Store at 4°C, in the dark, for up to 6 months. Digestion Buffer (for ~1–2 g of liver) Always prepare fresh digestion buffer on the day of harvest. Digestion buffer can be kept at room temperature during the harvest (1–2 h). FACS buffer Prepare in a sterile environment and filter through 0.22 μm PES membrane. Store at 4°C for up to 6 months. Blocking buffer for immunofluorescence Always prepare freshly on the day of staining for optimal results. Store at 4°C for up to 48 h if needed for next-day secondary antibody staining. Zombie Aqua Prepare fresh for staining. Protect from light and keep on ice. Fc Block Prepare fresh for staining. Keep on ice. Flow cytometry antibody cocktail Prepare fresh for staining. Protect from light and keep on ice.

Step-by-step method details

Assemble perfusion pump and harvest table

Timing: 10 min Cover the surface of a plastic tray with a sheet of absorbent bench paper and then layer with two paper towels. Assemble tools including: surgical scissor, tweezer, suture, catheter, 2 cotton tips, razor blade, petri dishes, a stack of paper towels, pump, tubing for the pump, a bottle of PBS, a beaker, 70% ethanol, and biohazard bags for waste and carcass disposal. Attach the tubing to the peristaltic pump. Place the inlet end of the tubing into the bottle of PBS and the outlet end in a beaker. Start the pump until the air is cleared from the line and the entire tubing is filled with PBS (Figure 1A).
Figure 1

Illustrations for murine portal vein cannulation and subsequent processing into single-cell suspension for flow cytometry

(A) Set up of the variable-flow peristaltic pump for liver perfusion. The inlet of the tubing is placed in a bottle of autoclaved PBS with the outlet end of the tubing placed in a beaker until the catheter is attached and inserted into the portal vein. Arrows indicate the flow of PBS from inlet to outlet.

(B) Step-by-step procedure (left to right) for securing a half-knot around the portal vein, identifying the “flash” for successful portal cannulation, and completing liver perfusion.

(C) Schematic diagrams of enzymatic digestion and centrifugation protocols required to isolate non-parenchymal cells (including macrophages) from the liver.

Illustrations for murine portal vein cannulation and subsequent processing into single-cell suspension for flow cytometry (A) Set up of the variable-flow peristaltic pump for liver perfusion. The inlet of the tubing is placed in a bottle of autoclaved PBS with the outlet end of the tubing placed in a beaker until the catheter is attached and inserted into the portal vein. Arrows indicate the flow of PBS from inlet to outlet. (B) Step-by-step procedure (left to right) for securing a half-knot around the portal vein, identifying the “flash” for successful portal cannulation, and completing liver perfusion. (C) Schematic diagrams of enzymatic digestion and centrifugation protocols required to isolate non-parenchymal cells (including macrophages) from the liver.

Set up reagents for harvest

Timing: 10–30 min Prepare complete DMEM and FACS buffer (as described in materials and equipment). Prepare and label 3 sets of 50 mL conical tubes for each liver sample. Prepare digestion buffer (as described in materials and equipment) in the first set of 50 conical tubes. If collecting liver samples for IF, prepare 500 μL formalin solution in 1.5 mL Eppendorf tubes.

Perfusion of mouse liver

Timing: 15 min/mouse Proper perfusion of the liver is essential for maximum yield of liver macrophages for downstream analyses including, but not limited to, flow cytometry and immunofluorescence. Euthanize the mouse using carbon dioxide and subsequently perform cervical dislocation. Weigh and record the body weight of the mouse using a balance. Place the mouse in a prone position and sterilize the abdomen with 70% ethanol. Use a tweezer to lift up the skin near the genitals and make an incision with scissors. Pull the skin up to expose the body cavity membrane. Carefully cut open the peritoneal cavity membrane and move the small intestines aside to fully expose the liver. Locate the portal vein underneath the liver. Place a suture underneath the vein and secure a half-knot (Figure 1A). Cannulate the portal vein with the catheter until its tip reaches the branching point of the vein and passes the half-knotted suture. Tighten the knot to secure the catheter and remove the needle. A successful cannulation will result in a flash of blood into the catheter (Figure 1B; Methods video S1). Blood can be collected at this point from portal vein and/or IVC using 1mL syringe with a 21G × 1 ½ needle. Washing the tube with EDTA can be used to prevent clotting in the tube. Perfuse the portal vein with PBS using the peristaltic pump at a rate of 5 mL/min. After attaching the tubing onto the catheter immediately cut the inferior vena cava (IVC) below the liver to release blood and PBS from the liver. The liver should start to appear pale and beige in color. CRITICAL: Start the flow of PBS prior to inserting the tubing onto the catheter to prevent the introduction of air bubbles into the liver vasculature. Increase the flow rate to 10 mL/min. Apply gentle pressure on the IVC periodically and massage the liver with cotton tipped wood applicator to promote clearance of sinusoidal blood. Perfuse for a minimum of 3 min, or until the liver is completely pale (Figure 1A). The total perfusion volume of PBS should be about 30 mL. Remove catheter, suture, and gallbladder from the liver. Resect the liver from the body cavity (Figure 1A). Weigh and record total liver weight. Resect specific lobes of the liver for downstream analyses: for example, left medial and lateral lobe for flow cytometry and right lateral lobe for immunofluorescence. For flow cytometry between 0.5- 1 gm of tissue is recommended. (Further processing for immunofluorescence: see section Immunofluorescence of liver tissue) Depending on experimental question, the remaining liver tissue can be processed for other analyses including, but not limited to, histology, RNA, protein, or triglyceride quantification. For histology, submerge tissue into 500–750 μL formalin and incubate at 4°C for 24 h. Transfer tissue into 70% ethanol for subsequent paraffin embedding. For RNA, protein and triglyceride quantification, flash freeze tissue in liquid nitrogen and transfer to −80°C. It is a lab-dependent choice to decide which lobe to use for specific analysis, but it is encouraged to maintain consistency across different experimental groups and different experiments.

Enzymatic digestion and dissociation of liver tissue into single-cell suspension

Timing: 1.5 h This step describes the process of collagenase A digestion and differential centrifugation of liver tissue to prepare single-cell suspension for flow cytometry (Figure 1B). The cell suspension obtained after this step can also be used for alternative purposes, for example flow sorting, single-RNA sequencing, and/or ex vivo function assays. Weigh and record the liver tissue dedicated for flow cytometry. Place the liver in a petri dish and mince finely with a razor blade. Transfer the minced liver into a prepared digestion buffer and keep on ice until the end of the tissue harvest. At the end of the harvest, warm up all samples in a 37°C water bath for 5 min. Place the liver mixture on a shaker at 37°C with rotation for 30 min to digest. Vortex mixture after 15 min. Pre-wet 70 μm cell strainers placed onto new 50 mL falcon tubes with 5 mL cold complete DMEM. Transfer the digested liver mixture onto the cell strainers to allow pass-through of cells into the new 50 mL tubes. To inactive enzymatic activity, add 15 mL cold complete DMEM to the original tubes and carefully pour the rinse onto the cell strainers, while mashing any undigested liver pieces using the end of a syringe plunger. Centrifuge the strained cell suspension at 50 × g for 3 mins at 4°C to initially separate hepatocytes (pellet) and non-parenchymal cells (NPCs) (supernatant). Carefully pour the supernatant containing NPCs into a new 50 mL falcon tube. Discard pellet containing hepatocytes. Of note, ∼10% of KCs will be lost in the hepatocyte pellet. Hepatocyte pellet may be loose, use caution while pouring or use a pipette. Hepatocytes in the pellets can also be processed separately if of interest. Centrifuge the NPC suspension at 163 g for 7 min at 4°C to pellet the NPCs. The supernatant can be discarded. Resuspend the NPC pellet with 1 mL ACK lysis buffer and incubate for 5 min, at 20°C to lyse red blood cells. Add 10 mL PBS to wash. Centrifuge cell suspension at 163 g for 7 min at 4°C to re-pellet the NPCs. At this point the pellet should be pale and free of red blood cells. Resuspend the cells in 1 mL PBS and transfer to 1.5 mL Eppendorf tubes. Keep on ice. Pause point: Samples can be kept on ice for 1–2 h until ready to proceed to the next step. If pause, resuspend cells in 1 mL FACS buffer instead of PBS.

Staining for flow cytometry

Timing: 2 h This step details the method of staining liver NPCs for identifying macrophage populations (Kupffer cells (KCs), monocyte-KCs, hepatic lipid-associated macrophages, and monocytes) by flow cytometry. Key markers include CD45, CD11b, F4/80, TIM4, VSIG4, CLEC2, Ly6C and MHCII. For this protocol, the antibody panel in Table 1 will be used as an example.
Table 1

Example staining panel for analysis by BD X20 flow cytometer

ReagentFinal concentration
CD45 - BUV3951:100
CD11b - APC-Cy71:100
F4/80 - AF6471:100
CLEC2 - PE1:100
TIM4 - BV4211:500
VSIG4 - PE-Cy71:200
Ly6C - FITC1:100
MHC II - BV6051:300
CD11 c - BV7111:100
Zombie Aqua1:250

For exact antibodies, see key resources table.

Depending on experimental question, additional markers may be added, for example CD11c for dendritic cells, Ly6G for neutrophils, and/or Siglec F for eosinophils. This staining protocol utilizes Zombie Aqua to assess live/dead status of cells prior to staining for surface markers, hence requiring cell suspension to be free of BSA in step 36 Alternatively, DAPI can also be used to identify live cells. For DAPI staining, resuspend stained-cells in 1× DAPI solution in FACS buffer (according to manufacturer instruction) prior to analyzing samples on the cytometer. Pellet the cells using a bench-top centrifuge at 650 × g for 3.5 min at 4°C. If cells are in buffers containing BSA, wash off and exchange with PBS. Resuspend pellet with 100 μL Zombie Aqua solution at 1:250 dilution in PBS for live/dead stain. Incubate on ice and in the dark for 15 min. Wash the cells by adding 700 μL of FACS buffer to cell suspension. Pellet the cells at 650 × g for 3.5 min at 4°C. Aspirate the supernatant. Resuspend the pellet with 10 μL Fc block solution. Incubate on ice and in the dark for 5 min. Add 90 μL of antibody cocktail to the cell suspension. Resuspend and incubate on ice and in the dark for at least 45 min (Table 1). Wash the cells by adding 700 μL FACS buffer to the cell suspension. Pellet the cells at 650 × g for 3.5 min at 4°C. Aspirate the supernatant. Resuspend the cells in 300 μL FACS buffer. Filter the cell suspension through a 70-μm cell strainer into 5 mL polystyrene round-bottom flow tube and keep on ice in the dark. The samples are now ready to be analyzed on a flow cytometer. Example staining panel for analysis by BD X20 flow cytometer For exact antibodies, see key resources table.

Immunofluorescence of liver tissue

Timing: 1–2 days This step will explain immunofluorescence staining of macrophage markers in liver tissue. This can be used for analysis of identified NASH-associated macrophage markers, i.e., TREM2, Gpnmb and CD63, that have been proven difficult to analyze via flow cytometry (Daemen et al., 2021; Remmerie et al., 2020). Additional information that can be obtained is localization of macrophage subsets in the tissue as well as their proximity to other parenchymal and non-parenchymal cells. Following perfusion, harvest liver lobe and place the tissue into a tube containing formalin. It is critical to ensure the tissue is submerged in formalin, which typically requires a volume of 500–700 μL of fixative. We typically use the right medial liver lobe for IF. Keep on ice until all tissue is harvested. CRITICAL: To maintain tissue architecture of the liver, immediate incubation in fixative following tissue isolation is essential. Incubate at 4°C for 24 h. Transfer liver lobe to 750 μL 30% sucrose in PBS at 4°C for 24 h. A minimum incubation of 24 h is required, but incubation may be extended up to 72 h. Submerge and freeze liver lobe in OCT in mold and store at −80°C. Ideally, the liver will be sectioned in the horizontal plane and therefore the smooth dome shaped portion of the liver lobe should be placed face down in the OCT media. Cut 8 μM tissue sections using a cryostat on glass slides. Tissue sections can be stored at −80°C for several months. Prepare 50 mL blocking buffer fresh on the day of staining. Retrieve frozen slides from −80°C and let them air dry for 15–20 min at 20°C. CRITICAL: Prevent drying of the tissue sections at any step during the rest of the staining protocol. Incubate slides in PBS for 5 min in glass chamber, followed by 45 min in blocking buffer. Prepare primary antibody, 50 μL per section, in blocking buffer. Carefully extract slides from glass chamber and dry slides around the tissue sections with Kimwipe. Encircle sections with using a hydrophobic pen and add 50 μL primary antibody solution on each section. Keep slides in a container on wet paper towels 16–24 h at 4°C. Incubate slides in PBS for 5 min in glass chamber to wash and perform this step three times. Carefully extract slides from glass chamber and dry slides around the tissue sections with Kimwipe. Re-apply hydrophobic barrier with pen if necessary. Prepare secondary antibody solution and add 50 μL per section. Incubate for 1 h at room temperature in the dark. Incubate slides in PBS for 5 min in glass chamber to wash, 2 times. Prepare 50 mL Hoechst dye (1:25000) and add solution to slides in glass chamber. The nuclear dye should be prepared fresh for each experiment. Retrieve slides from glass chamber, dry carefully, and apply a small drop of prolong gold antifade reagent. Place cover slip on top and let slides dry for minimum of 1 h in dark. Imaging can be done with light or confocal microscopy. For optimal result, image within one week of staining.

Expected outcomes

The estimated yield per gram of liver tissue of CD45-positive cells and total F4/80hi macrophages can vary from 0.5–1.5 and 0.1–0.4 million cells, respectively. Exact cell number is dependent on many factors including perfusion quality and variation in digestion efficiency. The gating strategy described below may be used to identify the liver macrophage subsets previously described in NASH, but alternative gating strategies have been utilized by other labs (Remmerie et al., 2020; Tran et al., 2020). When using this protocol, it is expected that ∼ 90% of the CD45pos cells will be viable by live-dead staining. Although this can be somewhat variable, if the viability is below 70% this may indicate a problem with the isolation protocol. All liver macrophages are identified as F4/80hi, CD11bint (Figure 2A) and consist of the sinusoidal macrophages as well as a small number of liver capsular cells. The sinusoidal macrophages are composed of embryonically derived resident Kupffer cells (KCs), which can be identified by high expression of TIM4 (Figure 2B) and recruited monocyte-derived macrophages (MdMs) which are almost exclusively TIM4lo, although a subset of mo-KCs can begin to express TIM4 after several weeks in the liver (Figure 2B)(Scott et al., 2016). Typically, we have found the percentage of TIM4lo MdMs correlates with NASH severity. MdMs can be further subdivided into the monocyte-derived Kupffer cells (mo-KCs) which are TIM4lo, VSIG4hi (or CLEC4Fhi), and lipid-associated macrophages (LAMs), which are TIM4lo, VSIG4lo (Figure 2C)(Daemen et al., 2021). LAMs are likely the equivalent of the previously described NASH-associated macrophages (NAMs) as these populations both exhibit high expression of the markers TREM2, CD9, CD63 and Gpnmb (Xiong et al., 2019). The use of Ccr2-GFP or Cx3cr1-GFP reporter mice allows for further identification of Ccr2hi/Cx3cr1hi LAMs (C-LAMs) (Figure 2C)(Daemen et al., 2021). Several recent papers have also demonstrated CLEC2 as a marker of sinusoidal liver macrophages (Seidman et al., 2020). CLEC2 is highly expressed by most liver macrophages except for a small subpopulation of MdMs, which are high in Ccr2 and Cx3cr1. These cells are found in the C-LAM gate by flow cytometry (Figure 2D). This CLEC2lo population may include liver capsular cells and/or an early precursor of LAMs, but additional studies will be necessary to delineate the trajectory of these macrophages.
Figure 2

Example flow plots and immunofluorescence images to identify macrophage sub-populations in the NASH liver

(A) After gating for CD45-positive, live and singlet cells, liver macrophages can be identified as F4/80hi, CD11bint cells (orange circle).

(B) In a standard diet fed mouse almost all liver macrophages are resident TIM4hi Kupffer cells (KCs) (green box). In contrast, the NASH liver also contains significant numbers of recruited TIM4lo monocyte-derived macrophages (MdMs) (red box).

(C) TIM4lo macrophages can be further subdivided into VSIG4hi monocyte-KCs (Mo-KCs) and VSIG4lo lipid-associated macrophages (LAMs). Using Ccr2- or Cx3cr1-GFP reporter mice also facilitates the identification of Ccr2/Cx3cr1-GFP-positive LAMs (C-LAMs).

(D) Although most liver macrophages are CLEC2hi, there is a CLEC2lo subpopulation can be identified within the TIM4lo, VSIG4lo MdMs. These CLEC2lo macrophages express high levels of Ccr2/Cx3cr1.

(E) Monocytes can be identified by subsequent gating for CD11bhi, MHCIIlo, Ly6Chi, and low side scatter area (SSC-A). They can also be identified as Ccr2/Cx3cr1hi cells within the CD11bhi, MHCIIlo, Ly6Chi gate when using reporter mice.

(F and G) With immunofluorescence imaging LAMs can be identified using antibodies against Gpnmb or CD63 (red) and monocytes/C-LAMs by Ccr2-GFP (green). CLEC4F staining (white) allows for the identification of KCs as well as mo-KCs. A magnification image is shown to illustrate identification of macrophage subsets in the liver tissue. Nuclei are presented in blue. Scale bar is 50 μM.

Example flow plots and immunofluorescence images to identify macrophage sub-populations in the NASH liver (A) After gating for CD45-positive, live and singlet cells, liver macrophages can be identified as F4/80hi, CD11bint cells (orange circle). (B) In a standard diet fed mouse almost all liver macrophages are resident TIM4hi Kupffer cells (KCs) (green box). In contrast, the NASH liver also contains significant numbers of recruited TIM4lo monocyte-derived macrophages (MdMs) (red box). (C) TIM4lo macrophages can be further subdivided into VSIG4hi monocyte-KCs (Mo-KCs) and VSIG4lo lipid-associated macrophages (LAMs). Using Ccr2- or Cx3cr1-GFP reporter mice also facilitates the identification of Ccr2/Cx3cr1-GFP-positive LAMs (C-LAMs). (D) Although most liver macrophages are CLEC2hi, there is a CLEC2lo subpopulation can be identified within the TIM4lo, VSIG4lo MdMs. These CLEC2lo macrophages express high levels of Ccr2/Cx3cr1. (E) Monocytes can be identified by subsequent gating for CD11bhi, MHCIIlo, Ly6Chi, and low side scatter area (SSC-A). They can also be identified as Ccr2/Cx3cr1hi cells within the CD11bhi, MHCIIlo, Ly6Chi gate when using reporter mice. (F and G) With immunofluorescence imaging LAMs can be identified using antibodies against Gpnmb or CD63 (red) and monocytes/C-LAMs by Ccr2-GFP (green). CLEC4F staining (white) allows for the identification of KCs as well as mo-KCs. A magnification image is shown to illustrate identification of macrophage subsets in the liver tissue. Nuclei are presented in blue. Scale bar is 50 μM. Liver Ly6Chi monocytes can be found within the CD11bhi, F4/80int population and can be identified by gating for Ly6Chi, MHCIIlo, and SSClo (Figure 2E). Alternatively, antibodies to Ly6G and SiglecF can be used here to gate on neutrophils and eosinophils. When using Ccr2-GFP or Cx3cr1-GFP reporter mice, classical monocytes can also be identified as Ly6Chi, Ccr2hi/Cx3cr1hi (Figure 2E). Importantly, in the flow cytometric analysis, LAMs are currently identified by the absence of KC surface markers (TIM4, VSIG4), because flow cytometry of known LAM markers, i.e., TREM2, Gpnmb, and CD63, after tissue digestion has been challenging. Therefore, the presence and number of these cells also be assessed by immunofluorescence and confocal imaging. With this approach, co-staining of CD63 or Gpnmb with CLEC4F and Ccr2-GFP allows for simultaneous visualization and separation of LAMs, KCs/mo-KCs and C-LAMs, respectively (Figures 2F–2G). TIM4 staining can also be used to aid in the identification of Em-KCs vs. mo-KCs.

Quantification and statistical analysis

To quantify the flow cytometry absolute cell number should be corrected for the amount of liver tissue initially digested. Given the day-to-day variation in efficiency of cell isolation, same day comparison is recommended when analyzing parallel experimental groups. Quantification of immunofluorescence can be done using software such as ImageJ and can be expressed as number of cells per field of view. Quantification of total fluorescent area could also be performed, but importantly this does not correct for changes in macrophage size which may vary with disease state.

Limitations

The described protocol can be used for both standard diet healthy livers and NASH livers. However, when using healthy livers NPC pellet is larger when compared to the same tissue volume of a NASH liver. This can result in slow and difficult flow cytometry as the number of macrophages per given volume is reduced. When regularly using standard diet controls, the use of a percoll gradient may be preferred for better purification of macrophages, although this dramatically lowers the yield (Lynch et al., 2018). Fibrosis of the liver can also result in more difficult perfusion, digestion, and extraction of liver macrophages. Consequently, this may result in lower macrophage yield and/or favor extraction of specific macrophage populations, thereby giving distorted results on liver macrophage composition. Confirmation of flow cytometry results with immunofluorescence is therefore recommended. As an alternative direct perfusion of the liver with collagenase improves liver digestion and macrophage yield, however, this excludes the use of any tissue for immunofluorescence, histology, RNA, and protein analysis.

Troubleshooting

Problem 1

Unsuccessful cannulation of portal vein (step 14)

Potential solution

Cannulation of the IVC for perfusion is a possible alternative, though this often results in lower quality perfusion and subsequently lower cell yield. It is advised to practice portal vein cannulation until achieving reliable perfusion quality. Please see video file of portal vein cannulation (Methods video S1).

Problem 2

Low yield of liver macrophages (step 42) A low yield can result from low perfusion quality or incomplete digestion of the liver. Ensure the liver is properly perfused until a pale and beige appearance. In addition, ensure that the digestion buffer with collagenase is prepared fresh and the samples are heated to 37°C before digestion on the shaker. If a higher yield of macrophages is required, for example for flow sorting and/or plating of the macrophages, direct perfusion of the liver with collagenase coupled with digestion on the shaker can be considered. However, as described before this excluded use of liver tissue for other analyses.

Problem 3

Kupffer cell autofluorescence (step 42) KCs are extremely vacuolar macrophages and as such have significant autofluorescence in the green channel. Therefore, it is critical to include appropriate isotype control antibodies for the green channel to ensure that the positive signal is real. Similarly, when using GFP-reporter mice it is important to include some NTG littermate controls to confirm the findings, see figure 4 of the Daemen et al. manuscript (Daemen et al., 2021).

Problem 4

Low Kupffer cell viability (step 42) As mentioned above, it is expected that CD45 positive cells will have a viability of ∼ 90% using this protocol and gating strategy. If the viability is below 70% this may indicate a problem with the isolation protocol. The most likely steps that could lower cell viability are the collagenase digestion at 37 deg and/or the red cell lysis step. If either of these steps is allowed to continue beyond the recommended time, then immune cell viability can be compromised. It is also important to keep samples on ice with FACS buffer, rather than PBS to maximize cell viability.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Joel D. Schilling (schillij@wustl.edu).

Materials availability

This study did not generate new unique reagents.

Data and code availability

This study did not generate a new dataset or code for analysis.
REAGENT or RESOURCESOURCEIDENTIFIER
Antibodies

Rat monoclonal CD11b-APC-Cy7 (clone M1/70) - 1:100BioLegendCat# 101226
Rat monoclonal CD45-BUV395 (clone 30-F11)-1:100BD BiosciencesCat# 564279
Rat monoclonal F4/80-AF647 (clone BM8)- 1:100BioLegendCat# 123122
Rat monoclonal Ly6C-FITC (clone RB6-8C5)- 1:100BioLegendCat# 108406
Rat monoclonal MHCII-BV605 (clone M5/114.15.2) – 1:300BioLegendCat# 107639
Rat monoclonal TIM4-BV421 (clone 21H12)- 1:500BD BiosciencesCat# 742773
Rat monoclonal VSIG4-PeCy7 (clone NLA14)- 1:200Invitrogen-Thermo FisherCat# 25-5752-82
Rat monoclonal CLEC2-PE (clone 17D9) – 1:100BioLegendCat# 146104
Armenian Hamster monoclonal CD11c-BV711 (clone N418)- 1:100BioLegendCat# 117349
Chicken polyclonal GFP – unconjugated – 1:500AbcamCat# ab13970
Rat monoclonal F4/80 - unconjugated (clone BM8) – 1:200Invitrogen-Thermo FisherCat# 13-4801-85
Rat monoclonal CD63 - unconjugated (clone NGV-4) – 1:25BioLegendCat# 143902
Rabbit monoclonal Gpnmb - unconjugated (clone EPR18226-147) 1:50AbcamCat# 188222
Donkey anti-chicken AF488 – 1:500Jackson ImmunoResearchCat# 703-545-155
Goat polyclonal anti-CLEC4F-unconjugated – 1:100R&D SystemsCat# AF2784
Donkey anti-rat AF594 – 1:200Invitrogen-Thermo FisherCat# A21209
Donkey anti-rabbit AF647 – 1:500Jackson ImmunoResearchCat# 711-605-152
Goat anti-rabbit AF594 – 1:500Jackson ImmunoResearchCat# 111-585-003
Donkey anti-goat AF647 – 1:500Jackson ImmunoResearchCat# 705-605-003

Chemicals, peptides, and recombinant proteins

Collagenase ASigmaCat# C5138
DNase ISigmaCat# 10104159001
DMEMSigmaCat# D5671
L-glutamineSigmaCat# G7513
Penicillin-Streptomycin (P/S)GibcoCat# 15140-122
Fetal Bovine Serum (FBS)SigmaCat# F2442
Sodium PyruvateCorningCat# 25-000-CI
Bovine Serum Albumin (BSA)Lampire Biological LaboratoriesCat # 7500804
EDTACorningCat# 46-034-CI
ACK lysing bufferGibcoCat# A10492-01
Zombie AquaBioLegendCat# 423101
Fc BlockBD BiosciencesCat# 553143
10% Neutral buffered formalinSigmaCat# HT5011-1CS
SucroseIBI ScientificCat# 57-50-1
Tissue-Tek O.C.T.SakuraCat# 4583
Triton X-100SigmaCat# X100
Hoechst 33342Thermo FisherCat# 62249
ProLong Gold Antifade reagentThermo FisherCat# P36934
Phosphate buffered saline (PBS)SigmaCat# P3813

Experimental models: organisms/strains

Mouse C57BL/6jJackson LaboratoryCat# 000664
Mouse Ccr2-GFPDr. Kory LavineN/A

Software and algorithms

FlowJo v10.7.1FlowJohttps://www.flowjo.com/
Becton Dickinson X20 Flow CytometerBD Bioscienceshttps://www.bdbiosciences.com/en-us/applications/research-applications/multicolor-flow-cytometry

Other

NASH dietEnvigoCat# TD.190142
Fisherbrand Variable-Flow Peristaltic PumpFisher ScientificCat# 13-876-2
IV Catheter 24 g × ¾’’TerumoCat# SROX2419V
Ethilon Nylon Suture 4-0EthiconCat# 662G
Extension tubing set 42’’BaxterACT5612
Cotton tipsN/AN/A
Petridish 100 mm Not TC-treatedCorningCat# 351029
Personna Single Edge Razor bladesN/A94-120
70 μm Nylon Cell strainerCorningCat# 431751
TPP PES 0.22 μm filter media bottle (500 mL)MilliporeSigmaCat# Z760900

Complete DMEM

ReagentFinal concentrationAmount
DMEMn/a435 mL
Heat-inactivated FBS10% (v/v)50 mL
P/S (10 ,000U/mL)1% (v/v)5 mL
Sodium pyruvate (100 mM)1% (v/v)5 mL
L-glutamine solution (100 mM)1% (v/v)5 mL
Total500 mL

Prepare in a sterile environment and filter through 0.22 μm PES membrane. Store at 4°C, in the dark, for up to 6 months.

Digestion Buffer (for ~1–2 g of liver)

ReagentFinal concentrationAmount
DMEMn/a15 mL
Collagenase A (75 mg/mL)0.75mg/mL150 μL
DNaseI (5mg/mL)50μg/mL150 μL
Total15 mL

Always prepare fresh digestion buffer on the day of harvest. Digestion buffer can be kept at room temperature during the harvest (1–2 h).

FACS buffer

ReagentFinal concentrationAmount
PBSn/a498 mL
BSAn/a2.5 g
0.5 M EDTA2 mM2 mL
Total500 mL

Prepare in a sterile environment and filter through 0.22 μm PES membrane. Store at 4°C for up to 6 months.

Blocking buffer for immunofluorescence

ReagentFinal concentrationAmount
PBSn/a50 mL
BSA1%0.5 g
Triton ×1000.3% (v/v)150 μL
Total50 mL

Always prepare freshly on the day of staining for optimal results. Store at 4°C for up to 48 h if needed for next-day secondary antibody staining.

Zombie Aqua

ReagentFinal concentrationAmount
Zombie Aqua stock1:2500.4 μL
PBSn/a100 μL
Total100 μL

Prepare fresh for staining. Protect from light and keep on ice.

Fc Block

ReagentFinal concentrationAmount
Fc Block1:101 μL
FACS buffern/a9 μL
Total10 μL

Prepare fresh for staining. Keep on ice.

Flow cytometry antibody cocktail

ReagentFinal concentrationAmount
FACS buffern/a100 μL
Conjugated antibodies1:100–1:5000.2–1 μL
Total100 μL

Prepare fresh for staining. Protect from light and keep on ice.

  7 in total

1.  Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis.

Authors:  Jason S Seidman; Ty D Troutman; Mashito Sakai; Anita Gola; Nathanael J Spann; Hunter Bennett; Cassi M Bruni; Zhengyu Ouyang; Rick Z Li; Xiaoli Sun; BaoChau T Vu; Martina P Pasillas; Kaori M Ego; David Gosselin; Verena M Link; Ling-Wa Chong; Ronald M Evans; Bonne M Thompson; Jeffrey G McDonald; Mojgan Hosseini; Joseph L Witztum; Ronald N Germain; Christopher K Glass
Journal:  Immunity       Date:  2020-05-01       Impact factor: 31.745

2.  Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis.

Authors:  Sophie Tran; Ines Baba; Lucie Poupel; Sébastien Dussaud; Martine Moreau; Adélaïde Gélineau; Geneviève Marcelin; Elissa Magréau-Davy; Melissa Ouhachi; Philippe Lesnik; Alexandre Boissonnas; Wilfried Le Goff; Björn E Clausen; Laurent Yvan-Charvet; Florian Sennlaub; Thierry Huby; Emmanuel L Gautier
Journal:  Immunity       Date:  2020-06-19       Impact factor: 31.745

3.  Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis.

Authors:  Xuelian Xiong; Henry Kuang; Sahar Ansari; Tongyu Liu; Jianke Gong; Shuai Wang; Xu-Yun Zhao; Yewei Ji; Chuan Li; Liang Guo; Linkang Zhou; Zhimin Chen; Paola Leon-Mimila; Meng Ting Chung; Katsuo Kurabayashi; Judy Opp; Francisco Campos-Pérez; Hugo Villamil-Ramírez; Samuel Canizales-Quinteros; Robert Lyons; Carey N Lumeng; Beiyan Zhou; Ling Qi; Adriana Huertas-Vazquez; Aldons J Lusis; X Z Shawn Xu; Siming Li; Yonghao Yu; Jun Z Li; Jiandie D Lin
Journal:  Mol Cell       Date:  2019-08-08       Impact factor: 17.970

4.  Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH.

Authors:  Sabine Daemen; Anastasiia Gainullina; Gowri Kalugotla; Li He; Mandy M Chan; Joseph W Beals; Kim H Liss; Samuel Klein; Ariel E Feldstein; Brian N Finck; Maxim N Artyomov; Joel D Schilling
Journal:  Cell Rep       Date:  2021-01-12       Impact factor: 9.423

5.  Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells.

Authors:  Charlotte L Scott; Fang Zheng; Patrick De Baetselier; Liesbet Martens; Yvan Saeys; Sofie De Prijck; Saskia Lippens; Chloé Abels; Steve Schoonooghe; Geert Raes; Nick Devoogdt; Bart N Lambrecht; Alain Beschin; Martin Guilliams
Journal:  Nat Commun       Date:  2016-01-27       Impact factor: 14.919

6.  An efficient method to isolate Kupffer cells eliminating endothelial cell contamination and selective bias.

Authors:  Ruairi W Lynch; Catherine A Hawley; Antonella Pellicoro; Calum C Bain; John P Iredale; Stephen J Jenkins
Journal:  J Leukoc Biol       Date:  2018-04-01       Impact factor: 4.962

7.  Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver.

Authors:  Anneleen Remmerie; Liesbet Martens; Tinne Thoné; Angela Castoldi; Ruth Seurinck; Benjamin Pavie; Joris Roels; Bavo Vanneste; Sofie De Prijck; Mathias Vanhockerhout; Mushida Binte Abdul Latib; Lindsey Devisscher; Anne Hoorens; Johnny Bonnardel; Niels Vandamme; Anna Kremer; Peter Borghgraef; Hans Van Vlierberghe; Saskia Lippens; Edward Pearce; Yvan Saeys; Charlotte L Scott
Journal:  Immunity       Date:  2020-09-03       Impact factor: 31.745

  7 in total
  5 in total

1.  Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation.

Authors:  Satoru Sugimoto; Hebe Agustina Mena; Brian E Sansbury; Shio Kobayashi; Tadataka Tsuji; Chih-Hao Wang; Xuanzhi Yin; Tian Lian Huang; Joji Kusuyama; Sean D Kodani; Justin Darcy; Gerson Profeta; Nayara Pereira; Rudolph E Tanzi; Can Zhang; Thomas Serwold; Efi Kokkotou; Laurie J Goodyear; Aaron M Cypess; Luiz Osório Leiria; Matthew Spite; Yu-Hua Tseng
Journal:  Nat Metab       Date:  2022-06-27

2.  HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma.

Authors:  Qi-Tao Chen; Zhi-Yuan Zhang; Qiao-Ling Huang; Hang-Zi Chen; Wen-Bin Hong; Tianwei Lin; Wen-Xiu Zhao; Xiao-Min Wang; Cui-Yu Ju; Liu-Zheng Wu; Ya-Ying Huang; Pei-Pei Hou; Wei-Jia Wang; Dawang Zhou; Xianming Deng; Qiao Wu
Journal:  Nat Metab       Date:  2022-10-03

3.  Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity.

Authors:  Ming Yang; Eric T Kimchi; Kevin F Staveley-O'Carroll; Guangfu Li
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

4.  In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells.

Authors:  Victor A Naumenko; Daniil A Vishnevskiy; Aleksei A Stepanenko; Anastasiia O Sosnovtseva; Anastasiia A Chernysheva; Tatiana O Abakumova; Marat P Valikhov; Anastasiia V Lipatova; Maxim A Abakumov; Vladimir P Chekhonin
Journal:  Biomedicines       Date:  2022-07-13

Review 5.  Myeloid cells in alcoholic liver diseases: Mechanism and prospect.

Authors:  Wentao Xu; Miaomiao Wu; Bangjie Chen; Hua Wang
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.